Sagility LimitedQ2 FY27 Results & Financial Update
Sagility Limited: Q2 FY27 consolidated results and company financials – revenue ₹2,032.10 Cr, PAT ₹284.21 Cr. Explore reported YoY/QoQ movements, margins, business drivers and management commentary. This page does not provide a rating, target price or investment recommendation.
Quarter at a glanceReported figures and period changes.Changes compare like-for-like reported periods where available.
Find an answer
Ask this result
Chart · Market context
Sagility price & chart
Market price₹45.39
1Y return—Price return
Loading market chart…
TradingView Lightweight Charts™ · Copyright © 2025 TradingView, Inc.TradingView
Market chartPrice chart temporarily unavailableThe price chart could not be loaded right now. The reported financial results remain available above.
Spotted a factual error?Tell us the number, date or statement and we will re-check the underlying records and calculations.Report an error
Quarterly Results AnalysisExplore Sagility Q2 FY27 quarterly results and earnings: revenue, profit (PAT), EBITDA, margins, YoY and QoQ growth, order book or business updates where reported, financial performance and management commentary. Reported figures and Nivata calculations are shown separately; no buy, sell or hold recommendation is provided.
Quarter overview
Quarterly earnings analysis
Sagility Limited delivered consolidated revenue from operations of ₹2,032.10 crore for the quarter ended September 30, 2026, marking a 22.5% increase compared to ₹1,658.50 crore in the corresponding period of the previous year.
Profit after tax for Q2 FY27 stood at ₹284.21 crore, representing a 13.3% rise over the ₹250.83 crore reported in Q2 FY25 and a sequential expansion from ₹216.80 crore in Q1 FY27.
Operating performance was underpinned by broad-based momentum across core payer accounts and selective technology-led operational efficiencies, with adjusted EBITDA margin improving to 26.3% for the quarter.
The company integrated recent acquisitions, notably CareSeed LLC within its clinical practice, enhancing capabilities in HEDIS reporting and risk adjustment solutions for health plans.
Employee headcount reached 51,486 at the close of September 2026, while annualized voluntary attrition for employees with tenure exceeding 90 days moderated to 25.7% from 28.6% in the preceding quarter.
Reflecting management confidence in cash generation and balance sheet strength, the Board of Directors approved an interim dividend of ₹0.15 per equity share for the quarter.
01 · Business model
What does Sagility do?
Sagility Limited operates as a specialized healthcare operations partner, exclusively focused on supporting U.S. health plans, payers, providers, and pharmacy benefit managers to reduce administrative costs, enhance care quality, and improve overall member and provider experiences.
The company's primary revenue engine is derived from business process management (BPM) services tailored to the healthcare sector, encompassing claims processing, member enrollment, clinical operations, and revenue cycle management.
Sagility serves a concentrated roster of large-scale healthcare clients, including 7 of the top 10 U.S. health plans, supported by a global delivery footprint spanning 5 countries and 28 delivery centers.
The operating model combines deep domain expertise with technology-led transformations, embedding automation, analytics, and artificial intelligence directly into operations while maintaining strict regulatory and clinical compliance.
02 · Historical context
What shaped the business before this quarter
Previously known as Sagility India Limited, the company transitioned its legal identity to Sagility Limited.
On June 11, 2026, Sagility LLC acquired 100% equity interest in CareSeed LLC for a total contractual consideration of USD 30.0 million to expand quality measurement and risk adjustment solutions.
Following the implementation of New Labour Codes by the Government of India, the company previously recognized past service gratuity and leave encashment impacts in FY26 and Q1 FY27.
03 · Financial snapshot
Current quarter vs the two useful baselines
| Metric | Q2 FY27 | Year-ago | Previous quarter |
|---|---|---|---|
| Revenue from operations | ₹2,032.10 Cr | ₹1,658.50 Cr | ₹1,963.50 Cr |
| Total income | ₹2,044.95 Cr | ₹1,716.66 Cr | — |
| Profit before tax | ₹374.22 Cr | ₹326.81 Cr | ₹287.50 Cr |
| Profit after tax | ₹284.21 Cr | ₹250.83 Cr | ₹216.80 Cr |
| EPS | ₹0.61 | ₹0.53 | — |
04 · Why it moved
Why the quarter looked the way it did
What drove revenue
Revenue from the Payer vertical grew by 24.4% year-on-year to ₹1,826.20 crore, continuing to form the dominant share at 89.9% of total revenue.
Revenue from the Provider vertical registered ₹205.90 crore, representing an 8.2% increase compared to the corresponding quarter of the previous year.
Constant currency organic revenue growth for the quarter was recorded at 12.2% year-on-year, reflecting robust underlying volume expansion across major U.S. health plan accounts.
What drove margins
Employee benefit expenses stood at ₹1,229.44 crore for the quarter, reflecting continued investments in operations and delivery staff to support scaling business volumes.
Adjusted EBITDA margin reached 26.3% of revenue, benefiting from delivery efficiencies, operating leverage, and scale advantages as the company approaches seasonally stronger periods.
05 · Demand, customers & order book
Where demand is coming from
Sagility secured $40.2 million of Annual Contract Value (ACV) during Q2 FY27 from 31 existing clients and 1 new logo.
Active client groups expanded to 105 following the addition of 28 client groups during H1 FY27, including additions via the CareSeed acquisition.
Top 3, top 5, and top 10 client groups accounted for 60.1%, 70.3%, and 84.4% of trailing twelve-month revenues respectively.
06 · Segments, products & geography
Which parts of the business are doing the work
Segments and products
The Chief Operating Decision Maker evaluates performance as a single operating segment of business process management services dedicated to healthcare.
Geography and market mix
As of September 30, 2026, operations were executed across 28 delivery centers situated in 5 countries.
07 · Capacity, projects & execution
What is being built, commissioned or delivered
Capacity, production and utilisation
The company maintained 28 delivery sites globally, supporting scaled operations for top-tier U.S. health plans.
Projects, capex and execution
Capital expenditure for H1 FY27 included fixed asset additions of ₹116.80 crore to support expanding delivery infrastructure and AI-led tools.
08 · Strategy & new businesses
How the company is trying to change its growth mix
On October 21, 2026, Sagility (US) Holdings Inc. entered into a definitive agreement to acquire 100% equity in Chirok Health LLC for US$32.35 million, specializing in Clinical Documentation Integrity and medical coding.
The company accelerated its AI-led go-to-market strategy with new Statement of Work (SOW) wins and broader production deployments of automated tools like SmarTec Solutions.
09 · Reported developments
What changed operationally
Sagility was recognized as a Leader in Avasant's Healthcare Payer Business Process Transformation 2026 RadarView and won the Golden Peacock Award for ESG.
The Board approved an interim dividend of ₹0.15 per equity share, payable on or before November 21, 2026.
10 · Cash flow & balance sheet
Profit is one thing. Cash and funding tell another part of the story.
Net cash flows generated from operating activities for H1 FY27 reached ₹634.31 crore, reflecting stable profitability and collections.
Days Sales Outstanding (DSO) stood steady at 78 days as of September 30, 2026.
Capital allocation & funding
Total current borrowings stood at ₹425.46 crore as of September 30, 2026, down from ₹577.57 crore at March 31, 2026, reflecting active debt servicing.
11 · Beyond the numbers
What changed beyond the numbers
Reported update
ESOP Trust Establishment
Sagility established the Sagility ESOP Trust on July 7, 2026, to administer the employee stock options and performance stock units scheme 2026.
12 · Previous-quarter changes
What changed since the previous quarter
Adjusted EBITDA margin improved sequentially from 24.0% in Q1 FY27 to 26.3% in Q2 FY27.
13 · Key Q&A
The quarter, answered directly
What does Sagility do?
Sagility Limited operates as a specialized healthcare operations partner, exclusively focused on supporting U.S. health plans, payers, providers, and pharmacy benefit managers to reduce administrative costs, enhance care quality, and improve overall member and provider experiences.
What is the clearest takeaway from Q2 FY27?
Sagility Limited delivered consolidated revenue from operations of ₹2,032.10 crore for the quarter ended September 30, 2026, marking a 22.5% increase compared to ₹1,658.50 crore in the corresponding period of the previous year.
What drove revenue or demand?
Revenue from the Payer vertical grew by 24.4% year-on-year to ₹1,826.20 crore, continuing to form the dominant share at 89.9% of total revenue.
What mattered most for margins or profitability?
Employee benefit expenses stood at ₹1,229.44 crore for the quarter, reflecting continued investments in operations and delivery staff to support scaling business volumes.
What changed operationally beyond the headline numbers?
The company maintained 28 delivery sites globally, supporting scaled operations for top-tier U.S. health plans.
What should the next disclosure help confirm?
Monitor the formal consummation and closing conditions of the Chirok Health LLC acquisition announced in October 2026.
14 · Scenario calculator
Earnings sensitivity: what if growth and margins change?
Starting point
Build your own next-quarter scenario
Reported values are prefilled where a comparable basis is available. Otherwise, the field starts at 0. You can overwrite every field.
Example: enter 10 for 10% revenue growth. Enter -100 for a 1 percentage-point margin decline.
Scenario output
Scenario revenue / income₹0 cr
Scenario profit after tax₹0 cr
Profit change vs base₹0 cr (0%)
Scenario margin0%
Growth needed to keep profit flat after this margin move0%
The calculator holds the selected margin basis constant except for the basis-point adjustment you enter. It does not estimate tax, finance cost, dilution, working capital, valuation or share price.
15 · Next filing checkpoints
What the next disclosure can confirm or change
- 01
Chirok Health Acquisition Closure: Monitor the formal consummation and closing conditions of the Chirok Health LLC acquisition announced in October 2026.
- 02
AEP and Open Enrolment Execution: Track operational performance and volume ramp-up through the seasonally stronger Annual Enrollment Period (AEP) in the second half of FY27.
Learn the metrics
Need the concepts first?
Use Nivata’s plain-English guides to understand the accounting terms used in this brief before interpreting them.